On January 2, ProPublica and The New York Times co-published “When a Patient’s Death is Broadcast Without Permission,” a powerful article that explored legal and ethical questions posed by ABC’s “NY Med” and similar TV documentaries about actual medical dramas taking place in hospitals....
The shakeups continue at The American Journal of Bioethics as a co-editor resigns.
The American Journal of Bioethics has published what has to be one of the longest corrections ever for an academic journal. And yet it manages to beg more questions than it answers.
Antidote has received some disturbing communications from a bioethics journal we reported on. Read on for the back story.
The long held belief that we should not be allowed to buy or sell pieces of our own bodies is changing. What does that mean for the future of organ donation?
Bioethicist Leigh Turner describes how the stem cell company Celltex tried to intimidate him and his university when he asked the FDA to investigate the company.
Bioethicist Leigh Turner talks about why he sicced the FDA on Celltex and about academic rivalries in the world of bioethics.
Bioethicist Leigh Turner, recently under fire from a stem cell company he criticized for ethical problems, talks about his research on medical tourism.
When controversial bioethicist Glenn McGee quit his job as chief ethics advisor to Houston-based Celltex Therapeutics in February, the controversy over the company was on the verge of dying down. Until Celltex threatened a major public university and the very concept of free speech.
"You couldn't make up a story that good." Author Ricki Lewis talks how she reported and wrote her new nonfiction book about gene therapy.
